[1] |
NASCIMENTO A V, BOUSBAA H, FERREIRA D, et al. Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy[J]. Curr Drug Targets,2015,16(13):1448-1463. doi: 10.2174/1389450115666140528151649 |
[2] |
SAXENA A, BECKER D, PREESHAGUL I, et al. Therapeutic effects of repurposed therapies in non-small cell lung cancer: What Is Old Is New Again[J]. Oncologist,2015,20(8):934-945. doi: 10.1634/theoncologist.2015-0064 |
[3] |
PATRIGNANI P, PATRONO C. Aspirin and Cancer[J]. J Am Coll Cardiol,2016,68(9):967-976. doi: 10.1016/j.jacc.2016.05.083 |
[4] |
STRYJKOWSKA-GORA A, KARCZMAREK-BOROWSKA B, GORA T, et al. Statins and cancers[J]. Contemp Oncol (Pozn),2015,19(3):167-175. |
[5] |
GRONICH N, RENNERT G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates[J]. Nat Rev Clin Oncol,2013,10(11):625-642. doi: 10.1038/nrclinonc.2013.169 |
[6] |
VAN DYKE A L, COTE M L, PRYSAK G, et al. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women[J]. Cancer Epidemiol Biomarkers Prev,2008,17(1):148-157. doi: 10.1158/1055-9965.EPI-07-0517 |
[7] |
JIANG H Y, HUANG T B, XU L, et al. Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis[J]. PLoS One,2015,10(4):e0122962. doi: 10.1371/journal.pone.0122962 |
[8] |
LIN J J, EZER N, SIGEL K, et al. The effect of statins on survival in patients with stage IV lung cancer[J]. Lung Cancer,2016,99:137-142. doi: 10.1016/j.lungcan.2016.07.006 |
[9] |
HE Y, HUANG H, FARISCHON C, et al. Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells[J]. Oncol Rep,2017,37(2):953-960. doi: 10.3892/or.2017.5353 |
[10] |
MAKSIMOVA E, YIE T A, ROM W N. In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent[J]. Lung,2008,186(1):45-54. doi: 10.1007/s00408-007-9053-7 |
[11] |
HWANG K E, NA K S, PARK D S, et al. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin[J]. Invest New Drugs,2011,29(5):945-952. doi: 10.1007/s10637-010-9450-2 |
[12] |
CHEN J, LAN T, HOU J, et al. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1[J]. Int J Biochem Cell Biol,2012,44(5):759-769. doi: 10.1016/j.biocel.2012.01.015 |
[13] |
JIANG M J, DAI J J, GU D N, et al. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials[J]. Biochim Biophys Acta,2016,1866(2):163-176. |
[14] |
BRUEGEL M, TEUPSER D, HAFFNER I, et al. Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes[J]. Clin Exp Pharmacol Physiol,2006,33(12):1144-1149. doi: 10.1111/j.1440-1681.2006.04493.x |
[15] |
PARK K W, HWANG K K, CHO H J, et al. Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes[J]. Clin Chim Acta,2008,388(1-2):156-166. doi: 10.1016/j.cca.2007.10.027 |